Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients
Protocol Merck 318-00: A Double-Blind, Placebo-Controlled, Randomized, Parallel, Clinical Trial To Study The Effect Of Losartan Potassium On Endothelial Dysfunction And Insulin Resistance In Obese Patients With Impaired Fasting Glucose
Status: Enrolling
Updated:  12/31/1969
Hypertension Clinical Pharmacology Baylor Clinic
mi
from
Houston, TX
A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients
Protocol Merck 318-00: A Double-Blind, Placebo-Controlled, Randomized, Parallel, Clinical Trial To Study The Effect Of Losartan Potassium On Endothelial Dysfunction And Insulin Resistance In Obese Patients With Impaired Fasting Glucose
Status: Enrolling
Updated: 12/31/1969
Hypertension Clinical Pharmacology Baylor Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects
An Open-label, Single-Dose, Safety, Tolerability and Pharmacokinetic Study of Oral CTAP101 (Calcifediol) Extended-release Capsules in Japanese and Non-Japanese Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
Wcct Global, Llc
mi
from
Cypress, CA
Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects
An Open-label, Single-Dose, Safety, Tolerability and Pharmacokinetic Study of Oral CTAP101 (Calcifediol) Extended-release Capsules in Japanese and Non-Japanese Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Wcct Global, Llc
mi
from
Cypress, CA
Click here to add this to my saved trials
MINDD 3: Prediabetes and Delay Discounting
Delay Discounting as a Target for Self-Regulation in Prediabetes
Status: Enrolling
Updated:  12/31/1969
University at Buffalo, Department of Pediatrics, Division of Behavioral Medicine
mi
from
Buffalo, NY
MINDD 3: Prediabetes and Delay Discounting
Delay Discounting as a Target for Self-Regulation in Prediabetes
Status: Enrolling
Updated: 12/31/1969
University at Buffalo, Department of Pediatrics, Division of Behavioral Medicine
mi
from
Buffalo, NY
Click here to add this to my saved trials
Effects of Potato Resistant Starch Intake on Insulin Sensitivity, Related Metabolic Markers and Satiety
Effects of Potato Resistant Starch Intake on Insulin Sensitivity, Related Metabolic Markers and Satiety in Men and Women at Risk for Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Cathy Maki
mi
from
Boca Raton, FL
Effects of Potato Resistant Starch Intake on Insulin Sensitivity, Related Metabolic Markers and Satiety
Effects of Potato Resistant Starch Intake on Insulin Sensitivity, Related Metabolic Markers and Satiety in Men and Women at Risk for Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Cathy Maki
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Gainesville, FL
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
University of South Florida
mi
from
Tampa, FL
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
Indiana CTSI Clinical Research Center
mi
from
Indianapolis, IN
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
Indiana CTSI Clinical Research Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
University of Kentucky Medical Center
mi
from
Lexington, KY
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
University of Kentucky Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
Wayne State University Integrative Biosicences Center
mi
from
Detroit, MI
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
Wayne State University Integrative Biosicences Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
University of Missouri Health Care
mi
from
Columbia, MO
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
University of Missouri Health Care
mi
from
Columbia, MO
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
Morristown Medical Center
mi
from
Morristown, NJ
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
Morristown Medical Center
mi
from
Morristown, NJ
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
The University of Oklahoma Health Science Center
mi
from
Oklahoma City, OK
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
The University of Oklahoma Health Science Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
UPMC Childrens Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
UPMC Childrens Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated:  12/31/1969
Medical College of Milwaukee
mi
from
Milwaukee, WI
Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase (> 40 mg/Day Dose) in Adults With Phenylketonuria
Status: Enrolling
Updated: 12/31/1969
Medical College of Milwaukee
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Effect of Dietary Cholesterol on Plasma Lipids
A Randomized, Double-blind, Crossover Study on the Effect of Dietary Cholesterol on Plasma Lipids in Individuals With No Baseline Cholesterol Intake
Status: Enrolling
Updated:  12/31/1969
Physicians Committee for Responsible Medicine
mi
from
Washington,
Effect of Dietary Cholesterol on Plasma Lipids
A Randomized, Double-blind, Crossover Study on the Effect of Dietary Cholesterol on Plasma Lipids in Individuals With No Baseline Cholesterol Intake
Status: Enrolling
Updated: 12/31/1969
Physicians Committee for Responsible Medicine
mi
from
Washington,
Click here to add this to my saved trials
Low-Fat Vegan Diet Versus a Mediterranean Diet on Body Weight
A Randomized, Cross-Over Trial on the Effects of a Low-Fat Vegan Diet Versus a Mediterranean Diet on Body Weight
Status: Enrolling
Updated:  12/31/1969
Physicians Committee for Responsible Medicine
mi
from
Washington,
Low-Fat Vegan Diet Versus a Mediterranean Diet on Body Weight
A Randomized, Cross-Over Trial on the Effects of a Low-Fat Vegan Diet Versus a Mediterranean Diet on Body Weight
Status: Enrolling
Updated: 12/31/1969
Physicians Committee for Responsible Medicine
mi
from
Washington,
Click here to add this to my saved trials
Pathobiology and Reversibility of Prediabetes in a Biracial Cohort
Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Center, University of Tennessee Health Scienc Ctr
mi
from
Memphis, TN
Pathobiology and Reversibility of Prediabetes in a Biracial Cohort
Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Center, University of Tennessee Health Scienc Ctr
mi
from
Memphis, TN
Click here to add this to my saved trials
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
Study Comparing a Soybean Oil-Based vs Olive Oil-Based Lipid Emulsion: Effects on Endothelial Function, Inflammatory Markers, Oxidative Stress, Immune Function,Insulin Sensitivity and Carb Metabolism Intensive Care Unit Patients
Status: Enrolling
Updated:  12/31/1969
Grady Memorial Hospital
mi
from
Atlanta, GA
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
Study Comparing a Soybean Oil-Based vs Olive Oil-Based Lipid Emulsion: Effects on Endothelial Function, Inflammatory Markers, Oxidative Stress, Immune Function,Insulin Sensitivity and Carb Metabolism Intensive Care Unit Patients
Status: Enrolling
Updated: 12/31/1969
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
Study Comparing a Soybean Oil-Based vs Olive Oil-Based Lipid Emulsion: Effects on Endothelial Function, Inflammatory Markers, Oxidative Stress, Immune Function,Insulin Sensitivity and Carb Metabolism Intensive Care Unit Patients
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
Study Comparing a Soybean Oil-Based vs Olive Oil-Based Lipid Emulsion: Effects on Endothelial Function, Inflammatory Markers, Oxidative Stress, Immune Function,Insulin Sensitivity and Carb Metabolism Intensive Care Unit Patients
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Healthy Children and Adolescent
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Healthy Children and Adolescent
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Investigation of an Amino Acid Supplement on Glucose Levels in Obese Subjects
Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-diabetic Subjects
Status: Enrolling
Updated:  12/31/1969
UCLA Center for Human Nutriiton
mi
from
Los Angeles, CA
Investigation of an Amino Acid Supplement on Glucose Levels in Obese Subjects
Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-diabetic Subjects
Status: Enrolling
Updated: 12/31/1969
UCLA Center for Human Nutriiton
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes
Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes
Status: Enrolling
Updated:  12/31/1969
U.T.M.D. Anderson Cancer Center
mi
from
Houston, TX
Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes
Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes
Status: Enrolling
Updated: 12/31/1969
U.T.M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy
An Open-label, Randomized, Titration-blinded, Phase III Study of Efficacy, Safety and Tolerability Of Chronocort® Compared With Standard Glucocorticoid REeplacement Therapy in the Treatment of Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
Status: Enrolling
Updated:  12/31/1969
Diabetes & Endocrinology Consultants
mi
from
Morehead City, NC
Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy
An Open-label, Randomized, Titration-blinded, Phase III Study of Efficacy, Safety and Tolerability Of Chronocort® Compared With Standard Glucocorticoid REeplacement Therapy in the Treatment of Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
Status: Enrolling
Updated: 12/31/1969
Diabetes & Endocrinology Consultants
mi
from
Morehead City, NC
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Alabama Clinical Therapeutics, Llc
mi
from
Birmingham, AL
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Alabama Clinical Therapeutics, Llc
mi
from
Birmingham, AL
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Alabama Internal Medicine, PC
mi
from
Birmingham, AL
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Alabama Internal Medicine, PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Alabama Clinical Therapeutics
mi
from
Calera, AL
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Alabama Clinical Therapeutics
mi
from
Calera, AL
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Medical Affiliated Research Center, Inc.
mi
from
Huntsville, AL
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Medical Affiliated Research Center, Inc.
mi
from
Huntsville, AL
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Quality of Life Medical & Research Centers, LLC
mi
from
Tucson, AZ
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Quality of Life Medical & Research Centers, LLC
mi
from
Tucson, AZ
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Providence Clinical Research
mi
from
Burbank, CA
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Providence Clinical Research
mi
from
Burbank, CA
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
South Orange County Endocrinology
mi
from
Laguna Hills, CA
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
South Orange County Endocrinology
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Tower Urology
mi
from
Los Angeles, CA
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Tower Urology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Harbor-UCLA Medical Center, LA Biomedical Research Institute
mi
from
Torrance, CA
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Harbor-UCLA Medical Center, LA Biomedical Research Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Connecticut Clinical Research Center/ConnecTrials
mi
from
Middlebury, CT
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Connecticut Clinical Research Center/ConnecTrials
mi
from
Middlebury, CT
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
University of CT School of Medicine
mi
from
New Haven, CT
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
University of CT School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
South Florida Medical Research
mi
from
Aventura, FL
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
South Florida Medical Research
mi
from
Aventura, FL
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
University of Louisville
mi
from
Louisville, KY
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Boston University School of Medicine
mi
from
Boston, MA
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Maimonides Medical Center
mi
from
Brooklyn, NY
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Bruce R. GIlbert, MD, PhD, PC
mi
from
Great Neck, NY
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Bruce R. GIlbert, MD, PhD, PC
mi
from
Great Neck, NY
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
University Urology Associates
mi
from
New York, NY
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
University Urology Associates
mi
from
New York, NY
Click here to add this to my saved trials
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Michael A. Werner, MD PC
mi
from
Purchase, NY
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Michael A. Werner, MD PC
mi
from
Purchase, NY
Click here to add this to my saved trials